The Psycho-Genomics Research Institute has been established to encourage and develop psycho-genomic research in order to explore these links and identify better, broader and innovative new methods of preventing and treating cancer.
We are establishing the new cancer research front of psycho-genomics. Various experiments and clinical research have identified links between psychological, psychosocial, environmental factors and genes which may provide some bases for treatment and prevention of cancers.
In psycho-genomics research we take an integrated approach to prevent and treat cancers, taking into account different cancers and our psychology, emotional expression & processing, psychosocial, environmental, physiology, DNA, genes and genomic pathways.
In the future, we foreshadow that our research, and that of many others to follow, will produce a range of psycho-genomic remedies and treatments, each of which will consist of treatments that contain an integration of psychology, psychosocial, physiology and genomics.
You can help!
After over four years of research, workshops and discussion sessions to over 500 individuals, launch of its e-survey and wellbeing monitor and other analysis of fields of enquiry, we are now looking for help to undertake its psycho-genomics research findings through your financial assistance, research associations or partnerships to fund and progress its findings.
Thank you for taking the time to find out about our initiative to minimize the ravages of cancers and develop psycho-genomic approaches to greater enhanced cancer treatment and prevention strategies.
Story board Talking Point
New front to fight cancers
Psycho-Genomics Research Institute finds pathways exist from how we feel, how we do things and how we relate to others to our genes that can have positive adjustment and survival outcomes for cancer patients.
Psycho-Genomics Research Institute, in Albury, NSW, Australia, established to encourage and develop this cancer research, is seeking financial assistance, research associations or partnerships to fund and progress its findings.
“We feel that it is essential to bring together clinical and other research findings on cancers and emerging genes technologies. This is very critical to take the fight on cancers to the next level. We foresee that through our research initiative the attack on cancer will potentially take a new turn or at least add these new features” said Mr Richter, President, Psycho-Genomics Research Institute.
As most cancers have a genes based diagnosis, Psycho-Genomics Research Institute believes it is very important to arrive at a broader range of cancer treatment and prevention strategies. Various experiments and clinical research have identified links, for example, between stressors and psychological, psychosocial, environ-mental factors and genes which provide a basis for broader treatment and prevention outcomes.
Mr Richter notes that “it is critical to enlarge current cancer research that focuses on surgical, radiotherapy, chemotherapy and complementary medical interventions. Merging genes technologies with our human capabilities to treat and prevent cancers, provide us greater opportunities to find better treatment and prevention outcomes.”
“Our approach could provide significant health benefits as well as have potentially a significant impact on health spending and funding requirements. We should not shirk our responsibilities to find lasting treatment and prevention strategies by excluding anything that displays possible solutions.” Mr Richter said.
